Skip to main content
. 2018 Dec 18;8:17938. doi: 10.1038/s41598-018-36041-8

Figure 4.

Figure 4

Normalized degree centralities of significantly larger (red lines) and smaller (black lines) distances observed in resistant ensembles for 8 FDA-approved protease inhibitor complexes, namely ATV (a), DRV (b), FPV (c), IDV (d), LPV (e), NFV (f), SQV (g) and TPV (h). The top 5 residue positions with the highest connectivities are labelled at the peaks in each graph. Inserted underneath are the functional protease residues depicted as colored dots, namely the fulcrum Inline graphic, the elbow Inline graphic, the flap Inline graphic, the cantilever Inline graphic, the interface Inline graphic and the binding cavity residues Inline graphic.